averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAF
|
ENSG00000178573.6 | MAF bZIP transcription factor |
NRL
|
ENSG00000129535.8 | neural retina leucine zipper |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NRL | hg19_v2_chr14_-_24584138_24584223, hg19_v2_chr14_-_24553834_24553850 | 0.65 | 2.5e-27 | Click! |
MAF | hg19_v2_chr16_-_79633799_79633872 | 0.59 | 4.9e-22 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_33041378 | 34.76 |
ENST00000428995.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr16_+_226658 | 29.01 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr4_-_186125077 | 27.43 |
ENST00000458385.2
ENST00000514798.1 ENST00000296775.6 |
KIAA1430
|
KIAA1430 |
chr14_-_106237742 | 23.37 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr12_-_12491608 | 19.57 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr6_+_33048222 | 16.37 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chrX_+_128913906 | 16.06 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr2_-_37193606 | 15.74 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr6_+_32407619 | 15.22 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr7_+_26438187 | 14.02 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
chr17_+_1674982 | 13.69 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr3_+_183903811 | 13.09 |
ENST00000429586.2
ENST00000292808.5 |
ABCF3
|
ATP-binding cassette, sub-family F (GCN20), member 3 |
chr14_+_69865401 | 13.04 |
ENST00000556605.1
ENST00000336643.5 ENST00000031146.4 |
SLC39A9
|
solute carrier family 39, member 9 |
chr20_-_18774614 | 12.94 |
ENST00000412553.1
|
LINC00652
|
long intergenic non-protein coding RNA 652 |
chr3_-_194991876 | 12.80 |
ENST00000310380.6
|
XXYLT1
|
xyloside xylosyltransferase 1 |
chr17_+_1665345 | 12.77 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chrX_+_64708615 | 12.63 |
ENST00000338957.4
ENST00000423889.3 |
ZC3H12B
|
zinc finger CCCH-type containing 12B |
chr2_-_179672142 | 12.63 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
chr14_-_106092403 | 11.89 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr4_-_57976544 | 11.85 |
ENST00000295666.4
ENST00000537922.1 |
IGFBP7
|
insulin-like growth factor binding protein 7 |
chr6_-_33048483 | 11.53 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr6_+_31582961 | 11.50 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr4_+_128554081 | 11.35 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr11_+_31391381 | 11.17 |
ENST00000465995.1
ENST00000536040.1 |
DNAJC24
|
DnaJ (Hsp40) homolog, subfamily C, member 24 |
chr2_-_211168332 | 10.74 |
ENST00000341685.4
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr7_+_44143925 | 10.54 |
ENST00000223357.3
|
AEBP1
|
AE binding protein 1 |
chr22_+_22712087 | 10.52 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr19_+_39897453 | 10.50 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
chr1_+_22333943 | 10.44 |
ENST00000400271.2
|
CELA3A
|
chymotrypsin-like elastase family, member 3A |
chrX_+_13671225 | 10.36 |
ENST00000545566.1
ENST00000544987.1 ENST00000314720.4 |
TCEANC
|
transcription elongation factor A (SII) N-terminal and central domain containing |
chr14_-_77787198 | 10.29 |
ENST00000261534.4
|
POMT2
|
protein-O-mannosyltransferase 2 |
chr10_+_38299546 | 10.19 |
ENST00000374618.3
ENST00000432900.2 ENST00000458705.2 ENST00000469037.2 |
ZNF33A
|
zinc finger protein 33A |
chr10_-_44880491 | 10.15 |
ENST00000374426.2
ENST00000395795.4 ENST00000395794.2 ENST00000374429.2 ENST00000395793.3 ENST00000343575.6 |
CXCL12
|
chemokine (C-X-C motif) ligand 12 |
chr11_-_1330834 | 10.15 |
ENST00000525159.1
ENST00000317204.6 ENST00000542915.1 ENST00000527938.1 ENST00000530541.1 ENST00000263646.7 |
TOLLIP
|
toll interacting protein |
chr4_+_95972822 | 10.08 |
ENST00000509540.1
ENST00000440890.2 |
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr11_+_116700614 | 10.07 |
ENST00000375345.1
|
APOC3
|
apolipoprotein C-III |
chr11_-_2160180 | 10.02 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr22_+_42196666 | 9.98 |
ENST00000402061.3
ENST00000255784.5 |
CCDC134
|
coiled-coil domain containing 134 |
chr2_-_86333244 | 9.89 |
ENST00000263857.6
ENST00000409681.1 |
POLR1A
|
polymerase (RNA) I polypeptide A, 194kDa |
chr11_+_116700600 | 9.64 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
chr12_-_71182695 | 9.59 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr10_+_96443204 | 9.09 |
ENST00000339022.5
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
chr17_-_39769005 | 9.09 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr5_-_172198190 | 9.02 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr17_-_18218237 | 9.01 |
ENST00000542570.1
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr10_-_11653753 | 8.95 |
ENST00000609104.1
|
USP6NL
|
USP6 N-terminal like |
chr2_-_136873735 | 8.91 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr10_+_120967072 | 8.69 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr7_-_99679324 | 8.60 |
ENST00000292393.5
ENST00000413658.2 ENST00000412947.1 ENST00000441298.1 ENST00000449785.1 ENST00000299667.4 ENST00000424697.1 |
ZNF3
|
zinc finger protein 3 |
chr5_-_74062930 | 8.53 |
ENST00000509430.1
ENST00000345239.2 ENST00000427854.2 ENST00000506778.1 |
GFM2
|
G elongation factor, mitochondrial 2 |
chr16_+_2802623 | 8.49 |
ENST00000576924.1
ENST00000575009.1 ENST00000576415.1 ENST00000571378.1 |
SRRM2
|
serine/arginine repetitive matrix 2 |
chr9_-_127533582 | 8.48 |
ENST00000416460.2
|
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
chr1_-_1293904 | 8.34 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr14_+_77787227 | 8.30 |
ENST00000216465.5
ENST00000361389.4 ENST00000554279.1 ENST00000557639.1 ENST00000349555.3 ENST00000556627.1 ENST00000557053.1 |
GSTZ1
|
glutathione S-transferase zeta 1 |
chr19_-_51530916 | 8.25 |
ENST00000594768.1
|
KLK11
|
kallikrein-related peptidase 11 |
chr10_+_96443378 | 8.13 |
ENST00000285979.6
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
chr9_-_116840728 | 8.03 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr17_+_48610074 | 8.03 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
chr7_+_100136811 | 7.97 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
chr16_-_28550348 | 7.93 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr1_-_1297157 | 7.73 |
ENST00000477278.2
|
MXRA8
|
matrix-remodelling associated 8 |
chr19_+_45417921 | 7.69 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr3_-_122134882 | 7.66 |
ENST00000330689.4
|
WDR5B
|
WD repeat domain 5B |
chr15_+_90777424 | 7.51 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
chr6_+_41040678 | 7.51 |
ENST00000341376.6
ENST00000353205.5 |
NFYA
|
nuclear transcription factor Y, alpha |
chr12_-_11422630 | 7.49 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr19_-_19302931 | 7.42 |
ENST00000444486.3
ENST00000514819.3 ENST00000585679.1 ENST00000162023.5 |
MEF2BNB-MEF2B
MEF2BNB
MEF2B
|
MEF2BNB-MEF2B readthrough MEF2B neighbor myocyte enhancer factor 2B |
chr19_+_45417504 | 7.41 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
chr9_-_127533519 | 7.33 |
ENST00000487099.2
ENST00000344523.4 ENST00000373584.3 |
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
chr2_-_89385283 | 7.28 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr17_-_18218270 | 7.25 |
ENST00000321105.5
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr1_+_171283331 | 7.07 |
ENST00000367749.3
|
FMO4
|
flavin containing monooxygenase 4 |
chr19_+_45418067 | 7.07 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr5_+_149877334 | 6.91 |
ENST00000523767.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr11_-_133826852 | 6.86 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
chr9_+_132427883 | 6.83 |
ENST00000372469.4
|
PRRX2
|
paired related homeobox 2 |
chr3_-_50340996 | 6.83 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr1_-_161279749 | 6.81 |
ENST00000533357.1
ENST00000360451.6 ENST00000336559.4 |
MPZ
|
myelin protein zero |
chr1_-_16344500 | 6.78 |
ENST00000406363.2
ENST00000411503.1 ENST00000545268.1 ENST00000487046.1 |
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
chr11_-_5271122 | 6.70 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
chr11_-_2160611 | 6.70 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr19_-_3600549 | 6.69 |
ENST00000589966.1
|
TBXA2R
|
thromboxane A2 receptor |
chr19_+_52076425 | 6.68 |
ENST00000436511.2
|
ZNF175
|
zinc finger protein 175 |
chr1_+_33005020 | 6.65 |
ENST00000373510.4
ENST00000316459.4 |
ZBTB8A
|
zinc finger and BTB domain containing 8A |
chr11_-_119599794 | 6.61 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr7_+_142498725 | 6.51 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr21_-_44299626 | 6.51 |
ENST00000330317.2
ENST00000398208.2 |
WDR4
|
WD repeat domain 4 |
chr22_-_36013368 | 6.50 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
chr1_-_40237020 | 6.47 |
ENST00000327582.5
|
OXCT2
|
3-oxoacid CoA transferase 2 |
chr2_+_90458201 | 6.37 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chr14_-_23834411 | 6.35 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr20_-_17511962 | 6.26 |
ENST00000377873.3
|
BFSP1
|
beaded filament structural protein 1, filensin |
chr6_-_32634425 | 6.22 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr7_+_99816859 | 6.21 |
ENST00000317271.2
|
PVRIG
|
poliovirus receptor related immunoglobulin domain containing |
chr12_+_21679220 | 6.21 |
ENST00000256969.2
|
C12orf39
|
chromosome 12 open reading frame 39 |
chr22_+_22681656 | 6.11 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr9_-_35618364 | 6.11 |
ENST00000378431.1
ENST00000378430.3 ENST00000259633.4 |
CD72
|
CD72 molecule |
chr2_-_129076151 | 6.10 |
ENST00000259241.6
|
HS6ST1
|
heparan sulfate 6-O-sulfotransferase 1 |
chr7_+_40174565 | 6.05 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
chr14_+_100842735 | 6.02 |
ENST00000554998.1
ENST00000402312.3 ENST00000335290.6 ENST00000554175.1 |
WDR25
|
WD repeat domain 25 |
chr18_+_29171689 | 5.98 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr16_-_28550320 | 5.93 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chrX_+_84499081 | 5.88 |
ENST00000276123.3
|
ZNF711
|
zinc finger protein 711 |
chr15_-_88799661 | 5.87 |
ENST00000360948.2
ENST00000357724.2 ENST00000355254.2 ENST00000317501.3 |
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr6_+_32605195 | 5.84 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr19_+_45417812 | 5.78 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
chr11_-_6495101 | 5.78 |
ENST00000528227.1
ENST00000359518.3 ENST00000345851.3 ENST00000537602.1 |
TRIM3
|
tripartite motif containing 3 |
chr6_-_90025011 | 5.77 |
ENST00000402938.3
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr12_-_102874416 | 5.77 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr6_-_109330702 | 5.74 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
chr1_+_158325684 | 5.71 |
ENST00000368162.2
|
CD1E
|
CD1e molecule |
chr17_+_41052808 | 5.71 |
ENST00000592383.1
ENST00000253801.2 ENST00000585489.1 |
G6PC
|
glucose-6-phosphatase, catalytic subunit |
chr2_-_220173685 | 5.68 |
ENST00000423636.2
ENST00000442029.1 ENST00000412847.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
chr9_-_86571628 | 5.64 |
ENST00000376344.3
|
C9orf64
|
chromosome 9 open reading frame 64 |
chr11_-_116708302 | 5.63 |
ENST00000375320.1
ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1
|
apolipoprotein A-I |
chr9_+_139839686 | 5.61 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
chrX_+_84499038 | 5.59 |
ENST00000373165.3
|
ZNF711
|
zinc finger protein 711 |
chr2_-_25565377 | 5.51 |
ENST00000264709.3
ENST00000406659.3 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr7_-_128415844 | 5.48 |
ENST00000249389.2
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive |
chr2_-_87018784 | 5.45 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr3_+_38323785 | 5.45 |
ENST00000466887.1
ENST00000448498.1 |
SLC22A14
|
solute carrier family 22, member 14 |
chr19_-_16682987 | 5.41 |
ENST00000431408.1
ENST00000436553.2 ENST00000595753.1 |
SLC35E1
|
solute carrier family 35, member E1 |
chr2_-_211179883 | 5.36 |
ENST00000352451.3
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr11_+_2323236 | 5.33 |
ENST00000182290.4
|
TSPAN32
|
tetraspanin 32 |
chr11_-_57004658 | 5.29 |
ENST00000606794.1
|
APLNR
|
apelin receptor |
chr6_-_90024967 | 5.21 |
ENST00000602399.1
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr2_+_89184868 | 5.19 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr2_+_90273679 | 5.19 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr12_-_102874378 | 5.14 |
ENST00000456098.1
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chrX_-_154563889 | 5.13 |
ENST00000369449.2
ENST00000321926.4 |
CLIC2
|
chloride intracellular channel 2 |
chr1_+_36690011 | 5.09 |
ENST00000354618.5
ENST00000469141.2 ENST00000478853.1 |
THRAP3
|
thyroid hormone receptor associated protein 3 |
chr15_+_75118888 | 5.08 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
chr11_-_5276008 | 5.08 |
ENST00000336906.4
|
HBG2
|
hemoglobin, gamma G |
chr12_+_51318513 | 5.05 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
chr11_+_125365110 | 5.00 |
ENST00000527818.1
|
AP000708.1
|
AP000708.1 |
chr12_+_10366016 | 5.00 |
ENST00000546017.1
ENST00000535576.1 ENST00000539170.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr1_-_57431679 | 4.96 |
ENST00000371237.4
ENST00000535057.1 ENST00000543257.1 |
C8B
|
complement component 8, beta polypeptide |
chr3_+_129247479 | 4.92 |
ENST00000296271.3
|
RHO
|
rhodopsin |
chr1_+_200842083 | 4.91 |
ENST00000304244.2
|
GPR25
|
G protein-coupled receptor 25 |
chr14_+_75536280 | 4.91 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
chr1_-_151119087 | 4.83 |
ENST00000341697.3
ENST00000368914.3 |
SEMA6C
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
chrX_+_84498989 | 4.82 |
ENST00000395402.1
|
ZNF711
|
zinc finger protein 711 |
chr12_+_57610562 | 4.82 |
ENST00000349394.5
|
NXPH4
|
neurexophilin 4 |
chr7_-_36764004 | 4.81 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr1_-_152386732 | 4.80 |
ENST00000271835.3
|
CRNN
|
cornulin |
chr14_-_23479331 | 4.79 |
ENST00000397377.1
ENST00000397379.3 ENST00000406429.2 ENST00000341470.4 ENST00000555998.1 ENST00000397376.2 ENST00000553675.1 ENST00000553931.1 ENST00000555575.1 ENST00000553958.1 ENST00000555098.1 ENST00000556419.1 ENST00000553606.1 ENST00000299088.6 ENST00000554179.1 ENST00000397382.4 |
C14orf93
|
chromosome 14 open reading frame 93 |
chr11_-_10590118 | 4.79 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr9_+_82186682 | 4.79 |
ENST00000376552.2
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr20_-_35274548 | 4.77 |
ENST00000262866.4
|
SLA2
|
Src-like-adaptor 2 |
chr4_+_154178520 | 4.77 |
ENST00000433687.1
|
TRIM2
|
tripartite motif containing 2 |
chr3_+_152552685 | 4.76 |
ENST00000305097.3
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1 |
chr11_+_82868030 | 4.74 |
ENST00000298281.4
ENST00000530660.1 |
PCF11
|
PCF11 cleavage and polyadenylation factor subunit |
chr10_-_103815874 | 4.73 |
ENST00000370033.4
ENST00000311122.5 |
C10orf76
|
chromosome 10 open reading frame 76 |
chr5_-_131347501 | 4.73 |
ENST00000543479.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr5_+_80529104 | 4.69 |
ENST00000254035.4
ENST00000511719.1 ENST00000437669.1 ENST00000424301.2 ENST00000505060.1 |
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric) |
chr1_-_208084729 | 4.66 |
ENST00000310833.7
ENST00000356522.4 |
CD34
|
CD34 molecule |
chr12_-_11422739 | 4.61 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
chrX_+_11311533 | 4.60 |
ENST00000380714.3
ENST00000380712.3 ENST00000348912.4 |
AMELX
|
amelogenin, X-linked |
chr14_+_93118813 | 4.60 |
ENST00000556418.1
|
RIN3
|
Ras and Rab interactor 3 |
chr16_-_58004992 | 4.58 |
ENST00000564448.1
ENST00000251102.8 ENST00000311183.4 |
CNGB1
|
cyclic nucleotide gated channel beta 1 |
chr18_-_52969844 | 4.58 |
ENST00000561831.3
|
TCF4
|
transcription factor 4 |
chr19_+_37341752 | 4.58 |
ENST00000586933.1
ENST00000532141.1 ENST00000420450.1 ENST00000526123.1 |
ZNF345
|
zinc finger protein 345 |
chr1_-_16345245 | 4.57 |
ENST00000311890.9
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
chr2_+_189156638 | 4.56 |
ENST00000410051.1
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
chr4_+_78978724 | 4.55 |
ENST00000325942.6
ENST00000264895.6 ENST00000264899.6 |
FRAS1
|
Fraser syndrome 1 |
chr12_+_112204691 | 4.54 |
ENST00000416293.3
ENST00000261733.2 |
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial) |
chr12_+_57522258 | 4.52 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chrX_+_18443703 | 4.50 |
ENST00000379996.3
|
CDKL5
|
cyclin-dependent kinase-like 5 |
chr12_+_120105558 | 4.50 |
ENST00000229328.5
ENST00000541640.1 |
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
chr3_+_184097905 | 4.49 |
ENST00000450923.1
|
CHRD
|
chordin |
chr9_+_93589734 | 4.49 |
ENST00000375746.1
|
SYK
|
spleen tyrosine kinase |
chr1_+_62208091 | 4.48 |
ENST00000316485.6
ENST00000371158.2 |
INADL
|
InaD-like (Drosophila) |
chr12_-_4488872 | 4.45 |
ENST00000237837.1
|
FGF23
|
fibroblast growth factor 23 |
chr11_+_2323349 | 4.45 |
ENST00000381121.3
|
TSPAN32
|
tetraspanin 32 |
chr5_+_175792459 | 4.45 |
ENST00000310389.5
|
ARL10
|
ADP-ribosylation factor-like 10 |
chr9_+_132597722 | 4.45 |
ENST00000372429.3
ENST00000315480.4 ENST00000358355.1 |
USP20
|
ubiquitin specific peptidase 20 |
chr22_+_21128167 | 4.45 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr1_-_12677714 | 4.45 |
ENST00000376223.2
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3 |
chr2_+_128180842 | 4.43 |
ENST00000402125.2
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
chr3_+_184098065 | 4.41 |
ENST00000348986.3
|
CHRD
|
chordin |
chr4_+_100495864 | 4.40 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
chr11_+_28129795 | 4.39 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
chr1_-_201368653 | 4.37 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr9_+_140033862 | 4.35 |
ENST00000350902.5
ENST00000371550.4 ENST00000371546.4 ENST00000371555.4 ENST00000371553.3 ENST00000371559.4 ENST00000371560.3 |
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
chrX_+_70316005 | 4.35 |
ENST00000374259.3
|
FOXO4
|
forkhead box O4 |
chr16_+_70328680 | 4.35 |
ENST00000563206.1
ENST00000451014.3 ENST00000568625.1 |
DDX19B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B |
chr19_-_7812446 | 4.35 |
ENST00000394173.4
ENST00000301357.8 |
CD209
|
CD209 molecule |
chr17_-_10325261 | 4.34 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
chr21_+_34697258 | 4.33 |
ENST00000442071.1
ENST00000442357.2 |
IFNAR1
|
interferon (alpha, beta and omega) receptor 1 |
chr7_-_8301869 | 4.31 |
ENST00000402384.3
|
ICA1
|
islet cell autoantigen 1, 69kDa |
chr3_-_132441209 | 4.31 |
ENST00000383282.2
ENST00000326682.8 ENST00000343113.4 ENST00000337331.5 |
NPHP3
|
nephronophthisis 3 (adolescent) |
chr17_+_41003166 | 4.27 |
ENST00000308423.2
|
AOC3
|
amine oxidase, copper containing 3 |
chr9_+_4985016 | 4.27 |
ENST00000539801.1
|
JAK2
|
Janus kinase 2 |
chr6_+_31583761 | 4.25 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chr19_-_54784353 | 4.25 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr9_+_27109133 | 4.23 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
chr7_-_158622210 | 4.22 |
ENST00000251527.5
|
ESYT2
|
extended synaptotagmin-like protein 2 |
chr22_+_22786288 | 4.17 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr14_+_75536335 | 4.17 |
ENST00000554763.1
ENST00000439583.2 ENST00000526130.1 ENST00000525046.1 |
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
chr19_-_45004556 | 4.11 |
ENST00000587047.1
ENST00000391956.4 ENST00000221327.4 ENST00000586637.1 ENST00000591064.1 ENST00000592529.1 |
ZNF180
|
zinc finger protein 180 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 28.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
6.6 | 19.7 | GO:2000909 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
5.6 | 5.6 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
5.3 | 26.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
4.2 | 12.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
4.2 | 12.5 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
3.9 | 19.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
3.8 | 15.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
3.3 | 9.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.2 | 47.3 | GO:0015671 | oxygen transport(GO:0015671) |
2.6 | 10.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
2.5 | 12.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.5 | 9.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
2.4 | 7.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
2.3 | 6.8 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.2 | 6.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
2.1 | 6.3 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
2.1 | 10.3 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
2.0 | 10.1 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
2.0 | 10.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
2.0 | 2.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
2.0 | 5.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.0 | 5.9 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
1.9 | 5.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.9 | 16.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.7 | 11.8 | GO:0051414 | response to cortisol(GO:0051414) |
1.6 | 4.9 | GO:0009624 | response to nematode(GO:0009624) |
1.6 | 9.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.6 | 6.2 | GO:0050856 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.5 | 6.1 | GO:0003335 | corneocyte development(GO:0003335) |
1.5 | 4.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.5 | 4.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.5 | 10.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.5 | 4.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
1.5 | 4.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
1.5 | 4.4 | GO:0043449 | olfactory learning(GO:0008355) cellular alkene metabolic process(GO:0043449) |
1.4 | 7.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.4 | 11.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.4 | 1.4 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.4 | 2.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
1.3 | 4.0 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
1.3 | 2.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.3 | 3.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.3 | 6.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.3 | 8.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.3 | 3.8 | GO:0097178 | ruffle assembly(GO:0097178) |
1.2 | 4.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.2 | 2.4 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
1.2 | 4.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
1.2 | 4.7 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
1.2 | 3.5 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
1.2 | 18.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.1 | 3.4 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.1 | 4.5 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
1.1 | 3.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.1 | 4.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.1 | 4.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.1 | 7.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.1 | 91.6 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
1.1 | 4.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.1 | 8.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.1 | 2.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.0 | 15.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
1.0 | 3.1 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.0 | 2.0 | GO:0048867 | stem cell fate determination(GO:0048867) |
1.0 | 3.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.0 | 3.0 | GO:0001554 | luteolysis(GO:0001554) |
1.0 | 2.0 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.0 | 5.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.0 | 3.9 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
1.0 | 14.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.0 | 8.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 16.3 | GO:0006265 | DNA topological change(GO:0006265) |
1.0 | 2.9 | GO:0010193 | response to ozone(GO:0010193) |
0.9 | 1.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.9 | 5.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.9 | 10.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.9 | 16.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.9 | 2.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.9 | 6.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.9 | 3.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.9 | 2.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.8 | 19.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.8 | 5.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 3.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.8 | 2.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.8 | 2.3 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.8 | 54.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.8 | 3.1 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.8 | 4.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.8 | 4.5 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.8 | 2.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.7 | 2.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.7 | 4.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 10.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.7 | 5.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 7.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.7 | 3.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 2.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.7 | 2.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.7 | 10.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 1.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.7 | 16.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 3.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 3.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.7 | 3.9 | GO:0033133 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.7 | 3.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 3.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 4.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 3.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.6 | 10.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 3.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 1.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 4.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.6 | 3.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 4.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 1.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.6 | 5.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 6.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 1.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.5 | 4.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 2.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 4.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.6 | GO:0061056 | sclerotome development(GO:0061056) |
0.5 | 9.0 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.5 | 6.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.6 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.5 | 22.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 9.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.5 | 11.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 2.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 3.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 5.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 23.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.4 | 6.3 | GO:0035878 | nail development(GO:0035878) |
0.4 | 7.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 4.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 3.6 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) |
0.4 | 1.3 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.4 | 42.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.4 | 0.9 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.4 | 4.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 14.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 2.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 1.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.4 | 4.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 1.6 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.4 | 2.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 3.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.4 | 3.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 1.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.4 | 3.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 1.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.4 | 1.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 5.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 1.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 3.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 3.1 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 9.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 2.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.3 | 2.7 | GO:1901374 | acetate ester transport(GO:1901374) |
0.3 | 4.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 7.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 2.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.3 | 6.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 3.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 1.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 6.8 | GO:0098743 | cell aggregation(GO:0098743) |
0.3 | 0.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 1.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 0.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 7.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.3 | 9.1 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.3 | 1.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 6.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 2.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 6.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.3 | 5.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 2.0 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.3 | 3.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 2.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 15.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 2.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 12.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 1.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.3 | 2.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 2.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 5.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 2.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.3 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 | 1.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 6.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 5.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 7.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 2.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 4.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 3.9 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.2 | 1.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 2.5 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.0 | GO:0061146 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.4 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 9.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 5.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.6 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.6 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 1.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 3.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 1.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 4.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 1.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 1.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 3.1 | GO:0070168 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 2.4 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 0.9 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 2.5 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 3.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 3.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 1.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.2 | 2.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 1.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.2 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.2 | 2.3 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 3.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 2.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 2.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.2 | 3.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 3.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 1.2 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.1 | 0.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 2.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 1.0 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 0.7 | GO:0071222 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 3.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 1.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 5.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 3.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.1 | 3.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 2.0 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 1.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 5.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 1.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 3.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 1.4 | GO:0048738 | cardiac muscle tissue development(GO:0048738) |
0.1 | 4.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.8 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.2 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 3.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 12.4 | GO:0007586 | digestion(GO:0007586) |
0.1 | 1.0 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 2.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 2.4 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 8.5 | GO:0009451 | RNA modification(GO:0009451) |
0.1 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 2.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 5.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 4.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 3.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 3.9 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 4.6 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.8 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.3 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 1.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 2.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 3.0 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 1.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.8 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 8.3 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.1 | 0.3 | GO:0070627 | ferrous iron transport(GO:0015684) ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 2.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 3.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 1.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 1.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 1.1 | GO:0030855 | epithelial cell differentiation(GO:0030855) |
0.1 | 5.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 2.9 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.1 | 0.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 3.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 8.2 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.1 | 1.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.0 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0002545 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 2.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 1.4 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.6 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.0 | 0.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 1.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.6 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.0 | 1.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 1.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 1.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.8 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.3 | GO:0048298 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.6 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 1.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.7 | GO:0006811 | ion transport(GO:0006811) |
0.0 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 1.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.4 | GO:0044703 | multi-organism reproductive process(GO:0044703) |
0.0 | 0.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 3.3 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.1 | GO:0007000 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) nucleolus organization(GO:0007000) |
0.0 | 2.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.8 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 29.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.5 | 93.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.2 | 25.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.0 | 10.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
2.0 | 24.0 | GO:0043203 | axon hillock(GO:0043203) |
1.8 | 12.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.7 | 28.0 | GO:0042627 | chylomicron(GO:0042627) |
1.6 | 6.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.2 | 10.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.2 | 2.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 10.6 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 54.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.1 | 3.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.0 | 3.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 36.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 11.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 10.6 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.8 | 4.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.8 | 5.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 10.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 15.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 1.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.8 | 10.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 19.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.7 | 7.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 2.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 4.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 6.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 2.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.6 | 2.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 4.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 2.5 | GO:0036398 | TCR signalosome(GO:0036398) |
0.5 | 2.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 3.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.5 | 3.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.5 | 5.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 15.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.4 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 3.8 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.4 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 2.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 3.6 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 5.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 5.5 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.4 | 12.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 1.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 1.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.3 | 4.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 2.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 17.6 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 14.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 3.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 4.7 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 3.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.3 | 13.7 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 44.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 24.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 1.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 3.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 5.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 3.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 4.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.5 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 16.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.6 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 11.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 3.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 8.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 4.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 5.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 2.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 3.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.8 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 4.3 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 2.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 9.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 9.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 7.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 3.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 10.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 35.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 2.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.3 | GO:0031672 | A band(GO:0031672) |
0.1 | 7.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 16.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 7.1 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.1 | 6.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 6.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 11.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 6.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 10.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 5.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 22.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 64.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 4.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.9 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 2.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 13.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 6.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 3.7 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 11.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 4.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 5.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 2.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 5.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 25.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
5.5 | 77.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
4.7 | 28.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
4.3 | 13.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
3.6 | 47.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
3.0 | 9.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.9 | 8.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.7 | 16.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.6 | 12.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.3 | 6.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.2 | 6.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
2.0 | 8.0 | GO:0019862 | IgA binding(GO:0019862) |
1.8 | 7.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.7 | 6.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.7 | 10.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.6 | 3.3 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 6.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.6 | 4.8 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
1.5 | 4.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.5 | 15.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.5 | 3.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.5 | 19.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.5 | 4.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
1.4 | 4.3 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 5.7 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.3 | 5.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.3 | 3.9 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.3 | 3.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.3 | 12.5 | GO:0045545 | syndecan binding(GO:0045545) |
1.2 | 4.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.2 | 5.9 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.2 | 5.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.1 | 5.7 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 4.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.1 | 10.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.1 | 3.4 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.1 | 19.9 | GO:0070330 | aromatase activity(GO:0070330) |
1.1 | 3.2 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
1.1 | 5.3 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
1.0 | 3.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
1.0 | 57.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 3.1 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
1.0 | 4.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 10.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.9 | 5.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.9 | 4.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.9 | 4.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 7.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.9 | 7.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.9 | 2.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.9 | 3.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.9 | 3.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.8 | 11.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.8 | 2.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.8 | 4.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.8 | 15.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 7.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 23.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.8 | 2.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.8 | 15.5 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 3.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.7 | 3.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 4.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.7 | 30.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 2.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.7 | 11.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 7.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 2.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.7 | 2.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 3.3 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.7 | 2.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 4.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 3.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 2.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.6 | 2.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.6 | 4.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 10.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 6.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 1.8 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.6 | 2.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 6.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.6 | 2.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 4.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 2.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.6 | 5.7 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.6 | 2.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 6.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 3.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 4.4 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.5 | 11.3 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 2.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.5 | 2.4 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 15.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 3.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 7.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 5.6 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 15.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 7.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 14.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 23.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.5 | 5.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 2.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 3.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 1.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 4.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 5.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.5 | 5.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 3.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 5.2 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 3.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 3.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 1.3 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.4 | 12.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 3.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 5.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 11.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 3.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 4.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.4 | 2.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 4.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 6.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 1.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.4 | 13.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 3.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 5.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 8.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 4.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 8.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 1.7 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.3 | 2.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 4.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 6.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 5.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 3.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 8.2 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 81.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 3.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 5.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 9.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 28.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 6.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 7.7 | GO:0046873 | metal ion transmembrane transporter activity(GO:0046873) |
0.3 | 5.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.3 | 1.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 4.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 2.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 2.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 5.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 6.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 2.3 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 3.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 2.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 2.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 6.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 3.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 4.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 9.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 1.8 | GO:0045309 | phosphotyrosine binding(GO:0001784) protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 3.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 3.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 5.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 4.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 2.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 2.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 3.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.1 | 1.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 13.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 4.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 3.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 12.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.5 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 4.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 4.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 4.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 4.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 2.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 3.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 3.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 6.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 6.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 3.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 5.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 1.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 5.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 3.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.1 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.0 | 2.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 1.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 1.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 2.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 10.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0005253 | anion channel activity(GO:0005253) |
0.0 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 4.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 9.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 25.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 1.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 1.7 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 1.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 7.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 18.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 9.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 10.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 16.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 9.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 23.8 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 27.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 6.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 15.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 77.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 16.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 10.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 16.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 12.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 10.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 13.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 4.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 6.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 5.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 6.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 9.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 6.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 10.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 11.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 5.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 19.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 13.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 12.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 18.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 4.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 22.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 4.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 27.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 5.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 11.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 9.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 2.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 72.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.2 | 8.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.3 | 28.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 21.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.1 | 20.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.0 | 10.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 10.4 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 20.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 10.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 10.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 26.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 6.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 3.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 9.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 6.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 9.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 4.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 10.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 7.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 2.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 4.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 6.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 1.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 4.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 11.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 6.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 6.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 1.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 6.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 17.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 10.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 10.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 5.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 8.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 6.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 10.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 4.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 8.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 3.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 4.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 1.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 4.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 7.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 17.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 3.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 17.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 9.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 2.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 13.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 7.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 10.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 4.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 7.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 4.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 4.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 6.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 3.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.1 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 2.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 4.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 4.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 5.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 2.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 2.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |